Cargando…

Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-Syndrome

Background: The duration of anti-SARS-CoV-2-antibody detectability up to 12 months was examined in individuals after either single convalescence or convalescence and vaccination. Moreover, variables that might influence an anti-RBD/S1 antibody decline and the existence of a post-COVID-syndrome (PCS)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerhards, Catharina, Kittel, Maximilian, Ast, Volker, Bugert, Peter, Froelich, Matthias F., Hetjens, Michael, Haselmann, Verena, Neumaier, Michael, Thiaucourt, Margot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966735/ https://www.ncbi.nlm.nih.gov/pubmed/36851668 http://dx.doi.org/10.3390/v15020454

Ejemplares similares

Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection
por: Gerhards, Catharina, et al.
Publicado: (2021)

Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines
por: Gerhards, Catharina, et al.
Publicado: (2023)

Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples
por: Haselmann, Verena, et al.
Publicado: (2020)

Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay
por: Kittel, Maximilian, et al.
Publicado: (2021)

Exploring the Synergistic Potential of Radiomics and Laboratory Biomarkers for Enhanced Identification of Vulnerable COVID-19 Patients
por: Gerhards, Catharina, et al.
Publicado: (2023)

Anosmia Testing as Early Detection of SARS-CoV-2 Positivity; A Prospective Study under Screening Conditions
por: Jungbauer, Frederic, et al.
Publicado: (2022)

Clinical evaluation of commercial automated SARS-CoV-2 immunoassays
por: Kittel, Maximilian, et al.
Publicado: (2021)

Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection
por: Ast, Volker, et al.
Publicado: (2021)

Plasma-based S100B testing for management of traumatic brain injury in emergency setting
por: Haselmann, Verena, et al.
Publicado: (2021)

Triptychon: Usability evaluation and implementation of a web-based application for patients’ lab and vital parameters
por: Kittel, Maximilian, et al.
Publicado: (2023)

Results of a European-Wide External Quality Assessment (EQA) Scheme for Serological Detection of Anti-SARS-CoV-2 (CoVimm)—Pitfalls of Routine Application
por: Kittel, Maximilian, et al.
Publicado: (2022)

Liquid profiling of circulating tumor DNA in colorectal cancer: steps needed to achieve its full clinical value as standard care
por: Hedtke, Maren, et al.
Publicado: (2021)

Humoral Immunity of Unvaccinated COVID-19 Recovered vs. Naïve BNT162b2 Vaccinated Individuals: A Prospective Longitudinal Study
por: Joseph, Gili, et al.
Publicado: (2023)

Liquid Profiling for Cancer Patient Stratification in Precision Medicine—Current Status and Challenges for Successful Implementation in Standard Care
por: Haselmann, Verena, et al.
Publicado: (2022)

Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases
por: Rotterdam, Jil, et al.
Publicado: (2022)

Antibody Response to Vaccination with BNT162b2, mRNA-1273, and ChADOx1 in Patients with Myeloid and Lymphoid Neoplasms
por: Rotterdam, Jil, et al.
Publicado: (2021)

Lupus Antibody Mimicking Reduced Plasmatic Coagulation in a Patient With Atrial Fibrillation and Ischemic Stroke
por: Huseynov, Aydin, et al.
Publicado: (2020)

Neutralizing Antibody Response to BBIBP-CorV in Comparison with COVID-19 Recovered, Unvaccinated Individuals in a Sample of the Pakistani Population
por: Aijaz, Javeria, et al.
Publicado: (2022)

Durability of the humoral immune response in recovered COVID-19 patients
por: Mahallawi, Waleed, et al.
Publicado: (2021)

Prolonged humoral and cellular immunity in COVID-19-recovered patients()
por: Alsayb, May A., et al.
Publicado: (2021)

Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients
por: Peghin, Maddalena, et al.
Publicado: (2022)

Profiles of US Hispanics Unvaccinated for COVID-19
por: Piper, Brian J., et al.
Publicado: (2022)

‘Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients’: authors' response
por: Peghin, Maddalena, et al.
Publicado: (2022)

COVID-19: stigmatising the unvaccinated is not justified
por: Kampf, Günter
Publicado: (2021)

Assessment of Antibody and T-Cell Responses to the SARS-CoV-2 Virus and Omicron Variant in Unvaccinated Individuals Recovered From COVID-19 Infection in Wuhan, China
por: Guo, Li, et al.
Publicado: (2022)

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
por: Özbay Kurt, Feyza Gül, et al.
Publicado: (2022)

Treating the Unvaccinated COVID-19 Patient with Compassion
por: Jacob, Enemona, et al.
Publicado: (2022)

COVID-19's lost generation of unvaccinated children
por: Walker, Damian, et al.
Publicado: (2021)

Re: Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients by Peghin et al.
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naïve and -Recovered Korean Individuals
por: Hwang, Ji-Young, et al.
Publicado: (2022)

The pandemic of the unvaccinated: a Covid-19 ethical dilemma
por: Zamir, Efrat, et al.
Publicado: (2023)

COVID-19 Encephalopathy: Delayed Onset in Unvaccinated Patients
por: Heller, Dana, et al.
Publicado: (2022)

The oldest unvaccinated Covid-19 survivors in South America
por: de Castro, Mateus V., et al.
Publicado: (2022)

Sensitivity of SARS-CoV-2 variant Delta to serum neutralization in BNT162b2 vaccinees and unvaccinated COVID-19 recovered cases
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2021)

The Potential and Emerging Role of Quantitative Imaging Biomarkers for Cancer Characterization
por: Tharmaseelan, Hishan, et al.
Publicado: (2022)

Rates of COVID-19 Among Unvaccinated Adults With Prior COVID-19
por: Ridgway, Jessica P., et al.
Publicado: (2022)

Caring for the Unvaccinated
por: Parker, William F.
Publicado: (2022)

COVID-19 differentiated measures for unvaccinated individuals: The need for clear goals and strong justifications
por: Chuan Voo, Teck, et al.
Publicado: (2022)

Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS–CoV‐2 in an Unvaccinated Cohort
por: Simon, David, et al.
Publicado: (2022)

Moral Outrage Toward Willfully Unvaccinated COVID-19 Patients
por: Dudzinski, Denise M.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tcnr06402viv37mc87gjbtn5tc